Dose response of continuous positive airway pressure on nasal symptoms, obstruction and inflammation in vivo and in vitro

Mohammed D. AlAhmari, Raymond J. Sapsford, Jadwiga A. Wedzicha, John R. Hurst

Source: Eur Respir J 2012; 40: 1180-1190
Journal Issue: November
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mohammed D. AlAhmari, Raymond J. Sapsford, Jadwiga A. Wedzicha, John R. Hurst. Dose response of continuous positive airway pressure on nasal symptoms, obstruction and inflammation in vivo and in vitro. Eur Respir J 2012; 40: 1180-1190

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of continuous positive airway pressure reduces airway reactivity in adults with asthma
Source: Eur Respir J 2013; 41: 317-322
Year: 2013



Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells
Source: ERJ Open Res, 6 (2) 00327-2019; 10.1183/23120541.00327-2019
Year: 2020



Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003



Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012



Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003



Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006

Basic mechanisms of development of airway structural changes in asthma
Source: Eur Respir J 2007; 29: 379-389
Year: 2007



Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011



Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007



Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Correlation between the asthma control, bronchial inflammation and airway response to hypoosmotic stimulus
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine
Source: Eur Respir J 2006; 28: Suppl. 50, 678s
Year: 2006

Continuous airway inflammation is related to the development of airway remodeling
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Peripheral airway involvement in asthma assessed by single-breath SF6 and He washout
Source: Eur Respir J 2003; 21: 1033-1039
Year: 2003



Exercise and airway physiology: interactions with immune and allergic responses
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=10
Year: 2005

Correlation of bronchial inflammation pattern and airway response to cold stimulus in patients with uncontrolled asthma
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Influence of airway epithelial cell thickness on hyperreactivity of airways of a murine asthma model
Source: Eur Respir J 2007; 30: Suppl. 51, 362s
Year: 2007

Walking with continuous positive airway pressure
Source: Eur Respir J 2006; 27: 853-855
Year: 2006



Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008